Cover Image

Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review

Abstract Background Febrile neutropenia (FN) is a prevalent and potentially life-threatening complication in patients with lymphoma receiving myelosuppressive chemotherapy. Pegfilgrastim is more effective than filgrastim as prophylaxis for FN. However, its usage has been limited because of its highe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Girma Tekle Gebremariam (Author), Atalay Mulu Fentie (Author), Kebede Beyene (Author), Beate Sander (Author), Gebremedhin Beedemariam Gebretekle (Author)
Format:	Book
Published:	BMC, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Health-related quality of life and treatment satisfaction of patients with cardiovascular disease in Ethiopia
by: Kebron Tito, et al.
Published: (2022)

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
by: Schwartzberg LS, et al.
Published: (2018)

Cost-utility analysis of caspofungin and fluconazole for primary treatment of invasive candidiasis and candidemia in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2022)

Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia
by: Atalay Mulu Fentie, et al.
Published: (2020)

Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast Cancer
by: Esse I. H. Akpo, et al.
Published: (2017)

NEUTROPENIA FEBRIL EN PEDIATRIA Febrile Neutropenia in Pedriatrics
by: Pio Lopez, et al.
Published: (2008)

Febrile neutropenia recurrence after chemotherapy in patients with breast cancer
by: Simone Yuriko Kameo, Glebson Moura Silva, Namie Okino Sawada, Mary Elizabeth de Santana
Published: (2020)

Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
by: Federica Cennamo, et al.
Published: (2021)

The risk factors for febrile neutropenia during chemotherapy in children with malignancy
by: Rini Sulviani, et al.
Published: (2007)

Uso do dispositivo Pegfilgrastim OBI para prevenção de neutropenia: revisão de escopo
by: Vivian do Prado Martins, et al.
Published: (2023)

The Potential Contribution of Dental Foci and Oral Mucositis to Febrile Neutropenia in Patients Treated With Myelosuppressive Chemotherapy for Solid Tumors and Lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2022)

A Protocol for a Scoping Review Comparative Bibliometric Analysis of Infectious Disease Research in Africa
by: Adrianna Perryman, et al.
Published: (2022)

Post chemotherapy febrile neutropenia. Length of stay and experience in our population
by: Íñigo Pérez-Heras, et al.
Published: (2020)

Oral microbial changes, oral mucositis and febrile neutropenia during myelosuppressive chemotherapy in patients diagnosed with a solid tumor or lymphoma
by: Judith A. E. M. Zecha, et al.
Published: (2024)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
by: Doaa Naeem, et al.
Published: (2018)

Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim
by: Henriette Kuehne, et al.
Published: (2024)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
by: José C. Álvarez, et al.
Published: (2021)

Comparison of CISNE and MASCC Score in Predicting Complications on Post Chemotherapy Febrile Neutropenia
by: Sharifah Shakinah, et al.
Published: (2024)

Low albumin at the onset of febrile neutropenia predicts adverse outcome in pediatric febrile neutropenia
by: Manideepa Maji, et al.
Published: (2022)

Factors Associated with Absolute Neutrophil Count Dynamics and Docetaxel-Adryamicin-Cyclophosphamide (TAC) Chemotherapy Induced Neutropenia During Extended Filgrastim Administration in Breast Cancer Patients
by: Ami Ashariati, et al.
Published: (2022)

Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases
by: Weycker Derek, et al.
Published: (2013)

Impact of malnutrition on febrile neutropenia in children with acute lymphoblastic leukemia during induction phase chemotherapy
by: Marshalla Agnes, et al.
Published: (2018)

Voriconazole in Prevention and Treatment of Febrile Neutropenia
by: Hamidreza Taghva Masoumi, et al.
Published: (2018)

Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
by: Karen A. Monuszko, et al.
Published: (2021)

Half of Prescribed Antibiotics Are Not Needed: A Pharmacist-Led Antimicrobial Stewardship Intervention and Clinical Outcomes in a Referral Hospital in Ethiopia
by: Gebremedhin Beedemariam Gebretekle, et al.
Published: (2020)

Outpatient management of febrile neutropenia in children with cancer
by: Ottavio Ziino, et al.
Published: (2011)

Chemotherapy adjuvant and chemotherapy-induced neutropenia
by: Yiu-Tai Li, et al.
Published: (2022)

Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
by: Alshari O, et al.
Published: (2021)

Health and non-health benefits and equity impacts of individual-level economic relief programs during epidemics/pandemics in high income settings: a scoping review
by: Adeteju Ogunbameru, et al.
Published: (2024)

Mothers/caregivers healthcare seeking behavior towards childhood illness in selected health centers in Addis Ababa, Ethiopia: a facility-based cross-sectional study
by: Nebiat Teshager Abegaz, et al.
Published: (2019)

Predictors of mortality in pediatric oncology patients with febrile neutropenia
by: Aditya Dabas, et al.
Published: (2022)

Optimizing Empiric Vancomycin Use in Febrile Neutropenia Patients
by: Nicole Tadros, et al.
Published: (2021)

Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
by: Nagua Giurici, et al.
Published: (2011)

Health-related quality of life and its associated factors among hemophilia patients: experience from Ethiopian Hemophilia Treatment Centre
by: Sitina Iyar, et al.
Published: (2024)

Pharmacokinetics of Vancomycin among Patients with Chemotherapy-Associated Febrile Neutropenia: Which Would Be the Best Dosing to Obtain Appropriate Exposure?
by: Daniel Parra González, et al.
Published: (2022)

Multiday corticosteroids in cancer chemotherapy delay the diagnosis of and antimicrobial administration for febrile neutropenia: a double-center retrospective study
by: Hiroki Uda, et al.
Published: (2019)

Febrile neutropenia in childhood leukemia: Manado experience 1997 - 2006
by: Stefanus Gunawan, et al.
Published: (2009)

OP-056 The impact of time to antibiotic administration in febrile neutropenia
by: Aybike Koç, et al.
Published: (2024)

Microbiological profile and drug sensitivity patters in patients of febrile neutropenia
by: Shruti Kakkar, et al.
Published: (2022)

Evaluation of risk stratification strategies in pediatric patients with febrile neutropenia
by: Keegan Peter Janssens, et al.
Published: (2021)